UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 116

Sortiert nach

TIRO (Thyroid International Recommendations Online) now available in French

European annals of otorhinolaryngology, head and neck diseases, 2024-03, Vol.141 (2), p.117-117

2024

Volltextzugriff (PDF)

French consensus on management of head and neck cancer surgery during COVID-19 pandemic

European annals of otorhinolaryngology, head and neck diseases, 2020-05, Vol.137 (3), p.159-160

2020

Volltextzugriff (PDF)

Replacement of lip-split mandibulotomy by pull-through approach for T3–4 oral carcinomas

International journal of oral and maxillofacial surgery, 2021-09, Vol.50 (9), p.1123-1130

2021

Volltextzugriff (PDF)

Occult nodal metastases in T1-T2cN0 oral squamous cell carcinoma: Correlation between sentinel node positivity and completion neck dissection analysis

Oral oncology, 2023-04, Vol.139, p.106338-106338, Article 106338

2023

Volltextzugriff (PDF)

Association of LIPI score with immune checkpoint inhibitors (ICI) outcomes in recurrent or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN) patients (pts)

Annals of oncology, 2018-10, Vol.29, p.viii387-viii387

2018

Volltextzugriff (PDF)

Molecular screening in advanced cancer patients with head and neck cancers: A retrospective analysis of the MOSCATO-01 trial

Annals of oncology, 2018-10, Vol.29, p.viii378-viii379

2018

Volltextzugriff (PDF)

Vocal fold mobility as the main prognostic factor of treatment outcomes and survival in stage II squamous cell carcinomas of the glottic larynx

Journal of laryngology and otology, 2015-09, Vol.129 (9), p.903-909

2015

Volltextzugriff (PDF)

OC-014: Molecular screening for cancer treatment optimization in head and neck cancer (MOSCATO 01)

Radiotherapy and oncology, 2015-02, Vol.114, p.12-12

2015

Volltextzugriff (PDF)

New insights into peripherin expression in cochlear neurons

Neuroscience, 2007-11, Vol.150 (1), p.212-222

2007

Volltextzugriff (PDF)

855MO Adjuvant immunotherapy after salvage surgery in head and neck cancer squamous cell carcinoma (HNSCC): Phase II trial evaluating the efficacy and the toxicity of Nivolumab (ADJORL1)

Annals of oncology, 2023-10, Vol.34, p.S557-S557

2023

Volltextzugriff (PDF)

MO-0718 Improved tolerance and treatment intensity in patients with locally advanced head and neck cancer

Radiotherapy and oncology, 2023-05, Vol.182, p.S588-S589

2023

Volltextzugriff (PDF)

970P MEDINDUCTION: Phase I trial evaluating the safety of durvalumab in combination with docetaxel, cisplatin and 5-FU (DCF) as induction therapy for locally advanced squamous cell carcinoma of the head and neck (SCCHN)

Annals of oncology, 2020-09, Vol.31, p.S682-S683

2020

Volltextzugriff (PDF)

Role of locoregional disease in the definition of radioiodine refractory thyroid cancer

Annales d'endocrinologie, 2022-10, Vol.83 (5), p.339

2022

Volltextzugriff (PDF)

Immunodynamics of explanted human tumors for immuno‐oncology

EMBO molecular medicine, 2021-01, Vol.13 (1), p.e12850-n/a

2021

Volltextzugriff (PDF)

Clinical Relevance of Tumor Infiltrating Lymphocytes, PD-L1 Expression, and Correlation with HPV/P16 in Head and Neck Cancer Treated with Bio- or Chemoradiation Therapy

International journal of radiation oncology, biology, physics, 2017-10, Vol.99 (2), p.S203-S204

2017

Volltextzugriff (PDF)

EP-1158: Prognostic factors and role of neck dissection in N3 head and neck cancers treated with radiotherapy

Radiotherapy and oncology, 2018-04, Vol.127, p.S649-S649

2018

Volltextzugriff (PDF)

OC-0272: Twice daily reirradiation with cetuximab vs once daily chemoRT after surgery in head and neck cancer

Radiotherapy and oncology, 2018-04, Vol.127, p.S138-S138

2018

Volltextzugriff (PDF)

OC-0489: TAM and HLA class I expression in relation to HPV and clinical outcome in head and neck cancer

Radiotherapy and oncology, 2018-04, Vol.127, p.S251-S252

2018

Volltextzugriff (PDF)

MEDINDUCTION: Phase I trial evaluating the safety of durvalumab in combination with Docetaxel, Cisplatin and 5-FU (DCF) in induction for locally advanced squamous cell carcinoma of the head and neck (SCCHN)

Annals of oncology, 2017-09, Vol.28, p.v393-v394

2017

Volltextzugriff (PDF)

OC-0586 Immunological contexture basis of a prognostic radiomics signature in head and neck cancers

Radiotherapy and oncology, 2019-04, Vol.133, p.S307-S307

2019

Volltextzugriff (PDF)

Locally advanced nasal pyramid squamous cell carcinoma: our 15 years’ experience in a series of 35 total rhinectomies

Rhinology, 2020-01

2020

Volltextzugriff (PDF)

PO-0966: Prognostic value of tissue necrosis, CD34 MVD and CA-IX in head and neck cancer patients

Radiotherapy and oncology, 2017-05, Vol.123, p.S533-S534

2017

Volltextzugriff (PDF)

OC-0400: Prognostic impact of tumor infiltrating lymphocytes and PD-L1 expression in head and neck cancers

Radiotherapy and oncology, 2017-05, Vol.123, p.S213-S213

2017

Volltextzugriff (PDF)

Locally advanced nasal pyramid squamous cell carcinoma: our 15 yearsâ€™ experience in a series of 35 total rhinectomies

Rhinology, 2020-12, Vol.58 (6), p.638-640

2020

Volltextzugriff (PDF)

Supernumerary Outer Hair Cells Arise External to the Last Row of Sensory Cells in the Organ of Corti

Acta oto-laryngologica, 2001-01, Vol.121 (2), p.164-168

2001

Volltextzugriff (PDF)

1 – 25 von 116

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(105)
Mit Volltextzugriff
(104)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

TIRO (Thyroid International Recommendations Online) now available in French

French consensus on management of head and neck cancer surgery during COVID-19 pandemic

Replacement of lip-split mandibulotomy by pull-through approach for T3–4 oral carcinomas

Occult nodal metastases in T1-T2cN0 oral squamous cell carcinoma: Correlation between sentinel node positivity and completion neck dissection analysis

Association of LIPI score with immune checkpoint inhibitors (ICI) outcomes in recurrent or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN) patients (pts)

Molecular screening in advanced cancer patients with head and neck cancers: A retrospective analysis of the MOSCATO-01 trial

Vocal fold mobility as the main prognostic factor of treatment outcomes and survival in stage II squamous cell carcinomas of the glottic larynx

OC-014: Molecular screening for cancer treatment optimization in head and neck cancer (MOSCATO 01)

New insights into peripherin expression in cochlear neurons

855MO Adjuvant immunotherapy after salvage surgery in head and neck cancer squamous cell carcinoma (HNSCC): Phase II trial evaluating the efficacy and the toxicity of Nivolumab (ADJORL1)

MO-0718 Improved tolerance and treatment intensity in patients with locally advanced head and neck cancer

970P MEDINDUCTION: Phase I trial evaluating the safety of durvalumab in combination with docetaxel, cisplatin and 5-FU (DCF) as induction therapy for locally advanced squamous cell carcinoma of the head and neck (SCCHN)

Role of locoregional disease in the definition of radioiodine refractory thyroid cancer

Immunodynamics of explanted human tumors for immuno‐oncology

Clinical Relevance of Tumor Infiltrating Lymphocytes, PD-L1 Expression, and Correlation with HPV/P16 in Head and Neck Cancer Treated with Bio- or Chemoradiation Therapy

EP-1158: Prognostic factors and role of neck dissection in N3 head and neck cancers treated with radiotherapy

OC-0272: Twice daily reirradiation with cetuximab vs once daily chemoRT after surgery in head and neck cancer

OC-0489: TAM and HLA class I expression in relation to HPV and clinical outcome in head and neck cancer

MEDINDUCTION: Phase I trial evaluating the safety of durvalumab in combination with Docetaxel, Cisplatin and 5-FU (DCF) in induction for locally advanced squamous cell carcinoma of the head and neck (SCCHN)

OC-0586 Immunological contexture basis of a prognostic radiomics signature in head and neck cancers

Locally advanced nasal pyramid squamous cell carcinoma: our 15 years’ experience in a series of 35 total rhinectomies

PO-0966: Prognostic value of tissue necrosis, CD34 MVD and CA-IX in head and neck cancer patients

OC-0400: Prognostic impact of tumor infiltrating lymphocytes and PD-L1 expression in head and neck cancers

Locally advanced nasal pyramid squamous cell carcinoma: our 15 yearsâ€™ experience in a series of 35 total rhinectomies

Supernumerary Outer Hair Cells Arise External to the Last Row of Sensory Cells in the Organ of Corti

Suchergebnisse filtern